These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8329573)
61. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects. Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902 [TBL] [Abstract][Full Text] [Related]
62. Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour. Markwardt F; Richter M; Walsmann P; Riesener G; Paintz M Biomed Biochim Acta; 1990; 49(10):1103-8. PubMed ID: 1706917 [TBL] [Abstract][Full Text] [Related]
63. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470 [TBL] [Abstract][Full Text] [Related]
64. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases. Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709 [TBL] [Abstract][Full Text] [Related]
65. Desmopressin (DDAVP) and factor VIII: the tale as viewed from Milan (and Malmö). Mannucci PM J Thromb Haemost; 2003 Apr; 1(4):622-4. PubMed ID: 12871389 [No Abstract] [Full Text] [Related]
66. The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit. May GR; Paul W; Crook P; Butler KD; Page CP Br J Pharmacol; 1992 May; 106(1):133-8. PubMed ID: 1504722 [TBL] [Abstract][Full Text] [Related]
67. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin. Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295 [TBL] [Abstract][Full Text] [Related]
68. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor. Rodeghiero F; Castaman G; Di Bona E; Ruggeri M; Lombardi R; Mannucci PM Eur J Haematol; 1988 Feb; 40(2):163-7. PubMed ID: 3126081 [TBL] [Abstract][Full Text] [Related]
69. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure. Watson AJ; Keogh JA Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of hemostatic activity of desamino-D-arginine vasopressin (DDAVP) in uremic rats. Kaufman S; Stewart M; Gordon PA Thromb Res; 1994 Jan; 73(1):53-9. PubMed ID: 8178313 [TBL] [Abstract][Full Text] [Related]
72. Studies on the prolonged bleeding time in von Willebrand's disease. Mannucci PM; Pareti FI; Holmberg L; Nilsson IM; Ruggeri ZM J Lab Clin Med; 1976 Oct; 88(4):662-71. PubMed ID: 787458 [TBL] [Abstract][Full Text] [Related]
73. Desmopressin (DDAVP) for treatment of disorders of hemostasis. Mannucci PM Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987 [TBL] [Abstract][Full Text] [Related]
74. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate. Castaman G; Tosetto A; Rodeghiero F Am J Hematol; 1992 Oct; 41(2):132-6. PubMed ID: 1415174 [TBL] [Abstract][Full Text] [Related]
75. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP. Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080 [TBL] [Abstract][Full Text] [Related]
76. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models. Bacher P; Walenga JM; Iqbal O; Bajusz S; Breddin K; Fareed J Thromb Res; 1993 Aug; 71(4):251-63. PubMed ID: 8236155 [TBL] [Abstract][Full Text] [Related]
77. Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleeding. Nagakura T; Tabata K; Kira K; Hirota S; Clark R; Matsuura F; Hiyoshi H Thromb Res; 2013 Aug; 132(2):271-9. PubMed ID: 23827699 [TBL] [Abstract][Full Text] [Related]
78. A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Foster PA Thromb Haemost; 1995 Nov; 74(5):1370-8. PubMed ID: 8607125 [TBL] [Abstract][Full Text] [Related]